Plus Therapeutics

(NASDAQ) PSTV

Current Price$5.07

Market Cap$37.31M

Since IPO (2003)-100%

5 Year-100%

1 Year-34%

1 Month-7%

Plus Therapeutics Financials at a Glance

Market Cap

$37.31M

Revenue (TTM)

$5.18M

Net Income (TTM)

-$11.93M

EPS (TTM)

-$3.27

P/E Ratio

-1.66

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$5.07

Volume

97,738

Open

$5.33

Price

$5.07

Volume

97,738

Open

$5.33

Previous Close

$5.01

Daily Range

$5.00 - $5.46

52-Week Range

$2.90 - $23.43

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$5.07

Volume

97,738

Open

$5.33

Previous Close

$5.01

Daily Range

$5.00 - $5.46

52-Week Range

$2.90 - $23.43

Estimated Earnings Date

Aug 13, 2026

PSTV News

Plus Therapeutics Posts Q2 Profit Jump

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Plus Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Marc H. Hedrick, MD, MBA

Website

www.plustherapeutics.com

Headquarters

Austin, TX 78756, US

PSTV Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-4%

Net Income Margin

-2%

Return on Equity

Return on Capital

-2%

Return on Assets

-60%

Earnings Yield

-60.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.31M

Shares Outstanding

6.88M

Volume

97.74K

Avg. Volume

305.85K

Financials (TTM)

Gross Profit

$4.77M

Operating Income

-$15.30M

EBITDA

-$18.33M

Operating Cash Flow

-$20.78M

Capital Expenditure

-$67.00K

Free Cash Flow

-$20.84M

Cash & ST Invst.

$8.76M

Total Debt

$821.00K

Plus Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.03M

-2.9%

Gross Profit

$919.00K

+4.7%

Gross Margin

89.40%

N/A

Market Cap

$37.31M

N/A

Market Cap/Employee

$1.78M

N/A

Employees

N/A

Net Income

-$6.95M

+60.1%

EBITDA

-$6.82M

+49.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.02M

-69.4%

Total Debt

$725.00K

+1712.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$725.00K

+1712.5%

Return on Assets

-59.91%

N/A

Return on Invested Capital

-1.58%

N/A

Free Cash Flow

-$7.06M

-14.3%

Operating Cash Flow

-$6.24M

-1.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.41+1.44%

PLURPluri Inc.

PLURPluri Inc.$2.27+0.89%

VRCAVerrica Pharmaceuticals Inc.

VRCAVerrica Pharmaceuticals Inc.$5.87-2.57%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$3.62-5.24%

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.46-1.80%

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$3.62-1.36%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$2.08-6.95%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.59+0.01%

Questions About PSTV

What is the current price of Plus Therapeutics?

Plus Therapeutics is trading at $5.01 per share.

What is the 52-week range for Plus Therapeutics?

Over the past 52 weeks, Plus Therapeutics has traded between $2.90 and $23.43.

How much debt does Plus Therapeutics have?

As of the most recent reporting period, Plus Therapeutics reported total debt of $725.00K.

How much cash does Plus Therapeutics have on hand?

Plus Therapeutics reported $3.02M in cash and cash equivalents in its most recent financial results.

What is Plus Therapeutics’s dividend yield?

Plus Therapeutics does not currently have a dividend yield.

Plus Therapeutics

Plus Therapeutics Financials at a Glance

PSTV News

Plus Therapeutics Posts Q2 Profit Jump

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Plus Therapeutics

PSTV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Plus Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PSTV

What is the current price of Plus Therapeutics?

What is the 52-week range for Plus Therapeutics?

How much debt does Plus Therapeutics have?

How much cash does Plus Therapeutics have on hand?

What is Plus Therapeutics’s dividend yield?

Premium Investing Services